Sermorelin
Growth Hormone Releasing Hormone (1-29)
29 Amino Acids · MW: 3,357.88 Da
Amino Acids
29
Molecular Weight
3,357.88 Da
Half-life
~10-20 minutes
Research Score
4.6
Studies
287
Storage
N/A
What is Sermorelin?
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH. Previously FDA-approved as Geref for pediatric GH deficiency, it stimulates natural, pulsatile GH release from the pituitary. Widely used in anti-aging medicine for its physiological approach to GH optimization.
Key Benefits & Mechanisms
Stimulates natural GH release
Maintains pulsatile GH secretion
Improved deep sleep quality
Enhanced body composition
Anti-aging effects
Does not suppress pituitary function
FDA-approved safety track record
Research Summary
Sermorelin was FDA-approved (Geref) and has a strong clinical safety record. Discontinued commercially but remains widely used in compounding. Extensive clinical data supports efficacy for GH stimulation with a physiological release pattern.
Related Peptides
Ipamorelin
Growth Hormone Secretagogue
Ipamorelin is a selective growth hormone secretagogue that stimulates natural GH release without significantly affecting cortisol or prolactin levels. It is considered one of the safest and most selective GHRPs available.
PerformanceCJC-1295
Growth Hormone Releasing Hormone Analog
CJC-1295 is a modified GHRH analog with an extended half-life due to Drug Affinity Complex (DAC) technology. It promotes sustained, pulsatile GH release, improving body composition, recovery, and sleep quality.
PerformanceGHRP-6
Growth Hormone Releasing Peptide-6
GHRP-6 is a hexapeptide that stimulates the ghrelin receptor to promote growth hormone release. It is one of the earliest and most studied GH secretagogues, known for significant GH pulse induction and appetite stimulation.
PerformanceIGF-1 LR3
Insulin-like Growth Factor-1 Long R3
IGF-1 LR3 is a modified version of IGF-1 with 13 times the half-life of native IGF-1. It promotes anabolic signaling, muscle hyperplasia, and cellular repair with extended bioavailability.
Performance